Catherine Stehman-Breen

CEO at Chroma Medicine

Catherine Stehman-Breen is the CEO at Chroma Medicine. She became CEO in 2020 after serving as Chief Research and Development Officer at Obsidian Therapeutics.

Catherine has a BA from Colby College, a MA fro the University of Washington, and an MD from The University of Chicago Pritzker School of Medicine.

Links

Previous companies

Amgen logo
Sarepta Therapeutics logo
Obsidian Therapeutics logo
Regeneron logo

Timeline

  • CEO

    Current role

View in org chart